Injectable Drug Delivery Devices Market 2030: Precision Meets Efficiency
The global injectable drug delivery devices market is anticipated to reach USD 823.29 billion by 2030, expanding at a CAGR of 8.4% from 2024 to 2030. The market is being propelled by the rising prevalence of chronic diseases and rapid technological advancements in drug delivery systems. Additionally, government initiatives aimed at enhancing access to injectable therapies for chronic conditions are further supporting market expansion. Chronic diseases—including diabetes, cancer, and autoimmune disorders—continue to rise worldwide. According to the World Health Organization (WHO), illnesses such as diabetes, cancer, and cardiovascular diseases account for more than 70% of global deaths. These conditions frequently require long-term injectable treatments, significantly boosting the demand for advanced drug delivery devices. Moreover, the United Nations estimates that the global population aged 65 and above will reach 1.6 billion by 2050. As older adults are more prone to chr...